A carregar...
Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
BACKGROUND: Inhaled indacaterol (Onbrez Breezhaler), a long-acting β(2)-agonist, is approved in over 100 countries, including South Korea, as a once-daily bronchodilator for maintenance and treatment of chronic obstructive pulmonary disease (COPD). Here, we present an interim analysis of a post-mark...
Na minha lista:
| Publicado no: | Tuberc Respir Dis (Seoul) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256353/ https://ncbi.nlm.nih.gov/pubmed/28119747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2017.80.1.52 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|